Prime Medicine
PRME
PRME
116 hedge funds and large institutions have $266M invested in Prime Medicine in 2024 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 39 increasing their positions, 33 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
116
Holders Change
-6
Holders Change %
-4.92%
% of All Funds
1.68%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
14
Increased
39
Reduced
33
Closed
18
Calls
$2.28M
Puts
$249K
Net Calls
+$2.03M
Net Calls Change
+$1.54M
Top Buyers
| 1 |
Millennium Management
New York
|
$8.51M |
| 2 |
VPC
Vestal Point Capital
New York
|
$4.14M |
| 3 |
BlackRock
New York
|
$20.4M |
| 4 |
Wells Fargo
San Francisco,
California
|
$664K |
| 5 |
Goldman Sachs
New York
|
$852K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
126
Balyasny Asset Management
Chicago,
Illinois
| – | -$62.2K | -12,101 | Closed |
|
|
SO
127
STRS Ohio
Columbus,
Ohio
| – | -$51.4K | -10,000 | Closed |
|
|
OP
128
ORG Partners
Roanoke,
Indiana
| – | -$28.9K | -5,270 | Closed |
|
|
NC
129
nVerses Capital
Wellington,
Florida
| – | -$18K | -3,500 | Closed |
|
130
Group One Trading
Chicago,
Illinois
| – | -$10.2K | -1,975 | Closed |
|